Reportlinker Adds World Sleep Apnea Diagnostic and Therapeutic Devices Market Report

NEW YORK--(Business Wire)--
Reportlinker.com announces that a new market research report is available in its
catalogue.

World Sleep Apnea Diagnostic and Therapeutic Devices Market

http://www.reportlinker.com/p098389/World-Sleep-Apnea-Diagnostic-and-Therapeutic-Devices--Market.html

This report analyzes the worldwide markets for Sleep Apnea Diagnostic and
Therapeutic Devices in Millions of US$. The specific product segments analyzed
are Diagnostic Devices (Fixed PSG, Ambulatory PSG, & Others (include Screening
Devices)), and Therapeutic Devices (CPAP, Bi-Level PAP, Auto PAP, & Facial
Interfaces (Masks and Humidifiers)). The report provides separate comprehensive
analytics for the US, Japan, Europe, and Rest of World. Annual forecasts are
provided for each region for the period of 2000 through 2015. The report
profiles 57 companies including many key and niche players worldwide such as
Astro-Med Inc., Grass Technologies, Cadwell Laboratories, Inc., Cardinal Health,
Compumedics Ltd., Covidien Ltd, DeVilbiss Healthcare, Fisher & Paykel, Flaga
Group, Embla, Itamar Medical Ltd., Invacare Corporation, Medical Industries
America Inc., Natus Medical Inc., Bio-Logic, ResMed Inc., Respironics Inc.,
Stellate Systems, Inc., Teleflex Medical, Vital Signs Inc., and Weinmann Geräte
für Medizin GmbH+CCo. KG. Market data and analytics are derived from primary and
secondary research. Company profiles are mostly extracted from URL research and
reported select online sources.

SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC DEVICES MCP-3307 A GLOBAL STRATEGIC
BUSINESS REPORT

CONTENTS

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations I-1 Disclaimers I-2 Data
Interpretation & Reporting Level I-2 Quantitative Techniques & Analytics I-3
Product Definitions and Scope of Study I-3 Diagnostic Devices I-3 Fixed PSG I-3
Ambulatory PSG I-3 Others (include Screening Devices) I-3 Therapeutic Devices
I-3 CPAP I-4 Bi-Level PAP I-4 Auto PAP I-4 Facial Interfaces (Masks and
Humidifiers) I-4

II. EXECUTIVE SUMMARY

1. Market Dynamics II-1 Outlook II-1 Diagnostic Devices II-1 Therapeutic Devices
II-1 Issues & Trends II-1 Substantial Undiagnosed Patient Base Presents
Lucrative Opportunities II-1 Increased Awareness of Comorbid Conditions Spurs
Market Growth II-2 Technology Advancements Improve Patient Compliance II-2
Under-Penetration in CPAP Therapy Promises Significant Growth Prospects II-3
Industry Witnesses Consistent M&A Activity II-3

2. Competition and Market Structure II-5 Respironics and Resmed Dominate
Competitive Landscape II-5

Table 1: Global Market for Sleep Therapy (2004-2006): Revenues of Select Players
(In US$ Million) (includes corresponding Graph/Chart) II-5

Table 2: Global Market for Sleep Therapy (2004-2006): Revenues of Select Players
in Overseas Markets Excluding US (In US$ Million) (includes corresponding
Graph/Chart) II-6

Table 3: Global Market for Sleep Therapy (2007E-2009P): Percentage Share of
Select Players in Terms of Revenues (includes corresponding Graph/Chart) II-6

Table 4: Global Market for Sleep Therapy (2007E-2009P): Percentage Share of
Select Players in Terms of Revenues Generated Outside the US (includes
corresponding Graph/Chart) II-7

3. Sleep Apnea Diagnostics and Therapeutic Devices - A Synopsis II-8
Significance of Sleep II-8 Stages of Sleep II-8 Sleep Disorders and Stages of
Sleep II-8 Sleep Apnea- Introduction II-9 Forms of Apnea II-9 Central Sleep
Apnea II-9 Physiological Effects of CSA II-9 Mixed Apnea II-9 Complex Sleep
Apnea II-9 Obstructive Sleep Apnea - An Overview II-10 History II-10 Prevalence
II-10 Causes of OSA II-11 Symptoms of OSA II-11 Snoring and OSA II-11 Risks and
Complications Associated with Untreated Disorder II-12 Risk Groups II-12
Co-Morbid Conditions II-12 Heart Failure II-12 Hypertension II-12 Diabetes II-12
Fatigue II-13 Complications Associated with Surgery and Medications II-13
Financial Implications of Untreated OSA II-13 Pediatric OSA II-13 OSA Diagnosis
II-14 Interpreting AHI II-14 Monitoring and Recording Technologies II-14
Polysomnography (PSG) II-14 Fixed Polysomnographs II-15 Ambulatory
Polysomnographs II-15 Screening Devices II-16 Actigraphs II-16 OSA Therapies
II-16 Positive Airway Pressure (PAP) Treatment II-16 Continuous Positive Airway
Pressure (CPAP) II-16 Optional Features Available for CPAP Devices II-17 Bilevel
Positive Airway Pressure (BiPAP) II-17 Auto-titrating Positive Airway Pressure
(APAP) II-18 Masks II-18 Alternative Apnea Therapies II-18 Oral Appliances II-18
Surgical Procedures II-18 Tracheostomy II-19 Uvulo-palato-pharyngoplasty (UPPP)
II-19 Mandibular Myotomy II-19 Laser Assisted Uvuloplasty (LAUP) II-19
Somnoplasty or Radio Frequency (RF) Procedure II-19 Pillar Palatal Implant
System II-20 Other Surgical Therapies II-20 Over-the-Counter and Pharmacological
Therapies II-20 Behavioral and Lifestyle Changes II-20

4. Research Updates II-21 Research Finds Link Between Sleep Apnea and Heart
Risks in Children II-21 Sleep Disorders Increase Risk for Stroke and Blood
Pressure Patients II-21 Individuals with Sleep Apnea Face Greater Risk of
Cardiac Stress During Air Travel II-21 Sleep Apnea Screening Reduces Risk of
Post Operative Complications II-21

5. Product Launches/Introductions II-22 Covidien Launches Sandman Intro CPAP
Device with Heated Humidifier II-22 Itamar Medical Unveils Extended-Feature
Sleep Diagnosis System II-22 Weinmann Introduces Modular Masks II-22 Respironics
Rolls Out New Series of Masks II-22 Fisher & Paykel Introduces Opus Nasal
Pillows Mask II-22 Fisher & Paykel Introduces SleepStyle 200 Auto Series
Generators II-23 RespCare Introduces Hybrid CPAP Interface II-23 Teleflex
Launches ConchaTherm Neptune Heated Humidifier II-23 Teleflex Medical Unveils
New Series of Bravo Mask II-23 ResMed Rolls Out Mirage Swift Series of
Lightweight Masks II-23 Weinmann Launches SOMNObalance II-23 Weinmann Rolls Out
SOMNOcheck 2 R& K II-24 Cardinal Introduces Respiratory System for Infants II-24
Respironics Releases New Headgear for OSA Patients II-24 Teijin Launches Compact
CPAP Device II-24 Hoffman Launches Wearable CPAP Device II-24 Respironics
Introduces REMstar Plus M Sleep System II-24 Puritan Unveils New Nasal Mask
II-24 Teleflex Introduces Hybrid Universal Interface II-25

6. Recent Industry Activity II-26 Royal Philips Acquires Respironics II-26
Cardinal Health Signs Agreement with SleepNet II-26 Nihon Kohden Signs New
Agreement with Premier II-26 Tyco Healthcare is Now Covidien II-26 Natus
Acquires XLTEK II-26 Breas Medical Gets Clearance from FDA to Market iSleep 20i
II-27 ResMed Recalls 300,000 S8 Flow Generators II-27 Compumedics Strikes
Distribution Agreement with Medigas II-27 Cardinal Health Takes Over VIASYS
Healthcare II-27 VIASYS Acquires Tiara Medical II-27 Natus Acquires Bio-logic
Systems II-28

7. Focus on Select Players II-29 Astro-Med Inc. (US) II-29 Grass Technologies
(US) II-29 Cadwell Laboratories, Inc. (US) II-29 Cardinal Health (US) II-29
Compumedics Ltd (Australia) II-30 Covidien Ltd (US) II-30 DeVilbiss Healthcare
(US) II-30 Fisher & Paykel (New Zealand) II-31 Flaga Group (Iceland) II-31 Embla
(US) II-31 Itamar Medical Ltd. (Israel) II-31 Invacare Corporation (US) II-31
Medical Industries America Inc. (US) II-32 Natus Medical Inc. (US) II-32
Bio-Logic (US) II-32 ResMed Inc. (US) II-32 Respironics Inc (US) II-32 Stellate
Systems, Inc. (Canada) II-33 Teleflex Medical (US) II-33 Vital Signs Inc. (US)
II-33 Weinmann Geräte für Medizin GmbH+CCo. KG (Germany) II-34

8. Global Market Perspective II-35

Table 5: World Recent Past, Current & Future Analysis for Sleep Apnea Diagnostic
and Therapeutic Devices by Geographic Region - US, Japan, Europe and Rest of
World Markets Independently Analyzed with Annual Sales in US$ Million for Years
2000 through 2010 (includes corresponding Graph/Chart) II-35

Table 6: World Long-term Projections for Sleep Apnea Diagnostic and Therapeutic
Devices by Geographic Region - US, Japan, Europe and Rest of World Markets
Independently Analyzed with Annual Sales in US$ Million for Years 2011 through
2015 (includes corresponding Graph/Chart) II-36

Table 7: World 10-Year Perspective for Sleep Apnea Diagnostic and Therapeutic
Devices by Geographic Region - Percentage Breakdown of Value Sales for US,
Japan, Europe and Rest of World Markets for Years 2003, 2008, and 2012 (includes
corresponding Graph/Chart) II-37

Table 8: World Recent Past, Current & Future Analysis for Sleep Apnea Diagnostic
Devices by Geographic Region - US, Japan, Europe and Rest of World Markets
Independently Analyzed with Annual Sales in US$ Million for Years 2000 through
2010 (includes corresponding Graph/Chart) II-38

Table 9: World Long-term Projections for Sleep Apnea Diagnostic Devices by
Geographic Region - US, Japan, Europe and Rest of World Markets Independently
Analyzed with Annual Sales in US$ Million for Years 2011 through 2015 (includes
corresponding Graph/Chart) II-39

Table 10: World 10-Year Perspective for Sleep Apnea Diagnostic Devices by
Geographic Region - Percentage Breakdown of Value Sales for US, Japan, Europe
and Rest of World Markets for Years 2003, 2008, and 2012 (includes corresponding
Graph/Chart) II-40

Table 11: World Recent Past, Current & Future Analysis for Sleep Apnea
Diagnostic Devices by Product Segment - Clinical/Fixed PSG, Ambulatory PSG, and
Other Devices (Screening Devices) Markets Independently Analyzed with Annual
Sales in US$ Million for Years 2000 through 2010 (includes corresponding
Graph/Chart) II-41

Table 12: World Long-term Projections for Sleep Apnea Diagnostic Devices by
Product Segment - Clinical/Fixed PSG, Ambulatory PSG, and Other Devices
(Screening Devices) Markets Independently Analyzed with Annual Sales in US$
Million for Years 2011 through 2015 (includes corresponding Graph/Chart) II-41

Table 13: World 10-Year Perspective for Sleep Apnea Diagnostic Devices by
Product Segment - Percentage Breakdown of Value Sales for Clinical/Fixed PSG,
Ambulatory PSG, and Other Devices (Screening Devices) Markets for Years 2003,
2008, and 2012 (includes corresponding Graph/Chart) II-42

Table 14: World Recent Past, Current & Future Analysis for Clinical/Fixed PSG
Devices by Geographic Region - US, Japan, Europe and Rest of World Markets
Independently Analyzed with Annual Sales in US$ Million for Years 2000 through
2010 (includes corresponding Graph/Chart) II-43

Table 15: World Long-term Projections for Clinical/Fixed PSG Devices by
Geographic Region - US, Japan, Europe and Rest of World Markets Independently
Analyzed with Annual Sales in US$ Million for Years 2011 through 2015 (includes
corresponding Graph/Chart) II-44

Table 16: World 10-Year Perspective for Clinical/Fixed PSG Devices by Geographic
Region - Percentage Breakdown of Value Sales for US, Japan, Europe and Rest of
World Markets for Years 2003, 2008, and 2012 (includes corresponding
Graph/Chart) II-45

Table 17: World Recent Past, Current & Future Analysis for Ambulatory PSG
Devices by Geographic Region - US, Japan, Europe and Rest of World Markets
Independently Analyzed with Annual Sales in US$ Million for Years 2000 through
2010 (includes corresponding Graph/Chart) II-46

Table 18: World Long-term Projections for Ambulatory PSG Devices by Geographic
Region - US, Japan, Europe and Rest of World Markets Independently Analyzed with
Annual Sales in US$ Million for Years 2011 through 2015 (includes corresponding
Graph/Chart) II-47

Table 19: World 10-Year Perspective for Ambulatory PSG Devices by Geographic
Region - Percentage Breakdown of Value Sales for US, Japan, Europe and Rest of
World Markets for Years 2003, 2008, and 2012 (includes corresponding
Graph/Chart) II-48

Table 20: World Recent Past, Current & Future Analysis for Other Diagnostic
Devices (Screening Devices) by Geographic Region - US, Japan, Europe and Rest of
World Markets Independently Analyzed with Annual Sales in US$ Million for Years
2000 through 2010 (includes corresponding Graph/Chart) II-49

Table 21: World Long-term Projections for Other Diagnostic Devices (Screening
Devices) by Geographic Region - US, Japan, Europe and Rest of World Markets
Independently Analyzed with Annual Sales in US$ Million for Years 2011 through
2015 (includes corresponding Graph/Chart) II-50

Table 22: World 10-Year Perspective for Other Diagnostic Devices (Screening
Devices) by Geographic Region - Percentage Breakdown of Value Sales for US,
Japan, Europe and Rest of World Markets for Years 2003, 2008, and 2012 (includes
corresponding Graph/Chart) II-51

Table 23: World Recent Past, Current & Future Analysis for Sleep Apnea
Therapeutic Devices by Geographic Region - US, Japan, Europe and Rest of World
Markets Independently Analyzed with Annual Sales in US$ Million for Years 2000
through 2010 (includes corresponding Graph/Chart) II-52

Table 24: World Long-term Projections for Sleep Apnea Therapeutic Devices by
Geographic Region - US, Japan, Europe and Rest of World Markets Independently
Analyzed with Annual Sales in US$ Million for Years 2011 through 2015 (includes
corresponding Graph/Chart) II-53

Table 25: World 10-Year Perspective for Sleep Apnea Therapeutic Devices by
Geographic Region - Percentage Breakdown of Value Sales for US, Japan, Europe
and Rest of World Markets for Years 2003, 2008, and 2012 (includes corresponding
Graph/Chart) II-54

Table 26: World Recent Past, Current & Future Analysis for Sleep Apnea
Therapeutic Devices by Product Segment - CPAP, Auto CPAP, Bi-Level CPAP, and
Facial Interfaces (Masks and Humidifiers) Markets Independently Analyzed with
Annual Sales in US$ Million for Years 2000 through 2010 (includes corresponding
Graph/Chart) II-55

Table 27: World Long-term Projections for Sleep Apnea Therapeutic Devices by
Product Segment - CPAP, Auto PAP, Bi-Level PAP, and Facial Interfaces (Masks and
Humidifiers) Markets Independently Analyzed with Annual Sales in US$ Million for
Years 2011 through 2015 (includes corresponding Graph/Chart) II-56

Table 28: World 10-Year Perspective for Sleep Apnea Therapeutic Devices by
Product Segment - Percentage Breakdown of Value Sales for CPAP, Auto PAP,
Bi-Level PAP, and Facial Interfaces (Masks and Humidifiers) Markets for Years
2003, 2008, and 2012 (includes corresponding Graph/Chart) II-57

Table 29: World Recent Past, Current & Future Analysis for CPAP Devices by
Geographic Region - US, Japan, Europe and Rest of World Markets Independently
Analyzed with Annual Sales in US$ Million for Years 2000 through 2010 (includes
corresponding Graph/Chart) II-58

Table 30: World Long-term Projections for CPAP Devices by Geographic Region -
US, Japan, Europe and Rest of World Markets Independently Analyzed with Annual
Sales in US$ Million for Years 2011 through 2015 (includes corresponding
Graph/Chart) II-59

Table 31: World 10-Year Perspective for CPAP Devices by Geographic Region -
Percentage Breakdown of Value Sales for US, Japan, Europe and Rest of World
Markets for Years 2003, 2008, and 2012 (includes corresponding Graph/Chart)
II-60

Table 32: World Recent Past, Current & Future Analysis for Auto PAP Devices by
Geographic Region - US, Japan, Europe and Rest of World Markets Independently
Analyzed with Annual Sales in US$ Million for Years 2000 through 2010 (includes
corresponding Graph/Chart) II-61

Table 33: World Long-term Projections for Auto PAP Devices by Geographic Region
- US, Japan, Europe and Rest of World Markets Independently Analyzed with Annual
Sales in US$ Million for Years 2011 through 2015 (includes corresponding
Graph/Chart) II-62

Table 34: World 10-Year Perspective for Auto PAP Devices by Geographic Region -
Percentage Breakdown of Value Sales for US, Japan, Europe and Rest of World
Markets for Years 2003, 2008, and 2012 (includes corresponding Graph/Chart)
II-63

Table 35: World Recent Past, Current & Future Analysis for Bi-Level PAP Devices
by Geographic Region - US, Japan, Europe and Rest of World Markets Independently
Analyzed with Annual Sales in US$ Million for Years 2000 through 2010 (includes
corresponding Graph/Chart) II-64

Table 36: World Long-term Projections for Bi-Level PAP Devices by Geographic
Region - US, Japan, Europe and Rest of World Markets Independently Analyzed with
Annual Sales in US$ Million for Years 2011 through 2015 (includes corresponding
Graph/Chart) II-65

Table 37: World 10-Year Perspective for Bi-Level PAP Devices by Geographic
Region - Percentage Breakdown of Value Sales for US, Japan, Europe and Rest of
World Markets for Years 2003, 2008, and 2012 (includes corresponding
Graph/Chart) II-66

Table 38: World Recent Past, Current & Future Analysis for Facial Interfaces
(Masks and Humidifiers) by Geographic Region - US, Japan, Europe and Rest of
World Markets Independently Analyzed with Annual Sales in US$ Million for Years
2000 through 2010 (includes corresponding Graph/Chart) II-67

Table 39: World Long-term Projections for Facial Interfaces (Masks and
Humidifiers) by Geographic Region - US, Japan, Europe and Rest of World Markets
Independently Analyzed with Annual Sales in US$ Million for Years 2011 through
2015 (includes corresponding Graph/Chart) II-68

Table 40: World 10-Year Perspective for Facial Interfaces (Masks and
Humidifiers) by Geographic Region - Percentage Breakdown of Value Sales for US,
Japan, Europe and Rest of World Markets for Years 2003, 2008, and 2012 (includes
corresponding Graph/Chart) II-69

III. MARKET

1. The United States III-1 A.Market Analysis III-1 Outlook III-1 Trends and
Issues III-1 Sleep Apnea Population and Penetration III-1 Pricing Trends III-2
Pricing Erosion on the Rise III-2 Premium Products to Command Higher Prices
III-2 Reimbursement Scenario III-2 CMS Includes Home Tests for Diagnosis and
Treatment of Sleep Apnea III-2 Home Sleep Tests Pose Significant Risk for
Clinical PSGs III-3 Reimbursement Scenario in Diagnostic and Therapy Devices
III-3 Reimbursement Rates of CPAP Equipment (New Devices): 2008 (In US$) III-4
Reimbursement Rates of CPAP Equipment (Rental): 2008 (In US$) III-5 Average
Replacement Schedules III-6 Competitive Landscape III-6

Table 41: US Market for Sleep Diagnostics Devices (2006) - Percentage Breakdown
of Revenues for Covidien (formerly Tyco), Embla, Respironics, Cardinal
Health/Viasys, Compumedics, Grass Technologies, Bio -Logics (Natus) and Others
(includes corresponding Graph/Chart) III-6

Table 42: US Market for Sleep Therapeutic Devices (2006) - Breakdown of Revenues
for Respironics, ResMed, Fisher & Paykel, and Covidien/Tyco in US$ Million
(includes corresponding Graph/Chart) III-7

Table 43: US Market for Sleep Therapy (2007E - 2009E) - Percentage Breakdown of
Revenues for Respironics, ResMed, Fisher & Paykel, Covidien/Tyco and Others
(includes corresponding Graph/Chart) III-7 A Focus on the CPAP Market III-8

Table 44: US Market for Sleep Apnea Devices (2007-2012) - Unit Sales for
Diagnostic Devices and Therapeutic Devices (includes corresponding Graph/Chart)
III-8

Table 45: US Market for Sleep Apnea Therapeutics (2007) - Percentage Breakdown
of Unit Sales of Masks by Nasal, Nasal Pillows, Full Face Masks and Mouth Masks
(includes corresponding Graph/Chart) III-8 Distribution III-8 A Review of the
Sleep Service Providers Market III-9 Greater Awareness Drives Trend Towards More
Number of Beds Per Facility III-9

Table 46: Number of Sleep Facilities in the US: 1997-2007 (includes
corresponding Graph/Chart) III-9 Changeover of the Sleep Lab III-10 Inadequate
Sleep Labs - a Bottle Neck for Diagnosis of OSA III-10 Inadequate Sleep Labs
Surge Development of Portable Sleep Monitoring III-10 DME Market for Sleep Apnea
Devices III-10

Table 47: US Market for CPAP Devices (2006) - Percentage Breakdown of Value
Sales by Durable Medical Equipment (DME) Suppliers for Apria Healthcare Group,
Lincare Holdings Inc, National Companies and Local Operators (includes
corresponding Graph/Chart) III-11 Product Launches III-11 Strategic Developments
III-14 Select Players III-15 B.Market Analytics III-19

Table 48: US Recent Past, Current & Future Analysis for Sleep Apnea Diagnostic
and Therapeutic Devices by Product Segment - Diagnostic Devices (Clinical/Fixed
PSG, Ambulatory PSG, and Others (Screening Devices)), and Therapeutic Devices
(CPAP, Auto PAP, Bi-Level PAP, and Facial Interfaces (Masks and Humidifiers))
Markets Independently Analyzed with Annual Sales in US$ Million for Years 2000
through 2010 (includes corresponding Graph/Chart) III-19

Table 49: US Long-term Projections for Sleep Apnea Diagnostic and Therapeutic
Devices by Product Segment - Diagnostic Devices (Clinical/Fixed PSG, Ambulatory
PSG, and Others (Screening Devices)), and Therapeutic Devices (CPAP, Auto PAP,
Bi-Level PAP, and Facial Interfaces (Masks and Humidifiers)) Markets
Independently Analyzed with Annual Sales in US$ Million for Years 2011 through
2015 (includes corresponding Graph/Chart) III-20

Table 50: US 10-Year Perspective for Sleep Apnea Diagnostic and Therapeutic
Devices by Product Segment - Percentage Breakdown of Value Sales for Diagnostic
Devices (Clinical/Fixed PSG, Ambulatory PSG, and Others (Screening Devices)),
and Therapeutic Devices (CPAP, Auto PAP, Bi-Level PAP, and Facial Interfaces
(Masks and Humidifiers)) Markets for Years 2003, 2008, and 2012 (includes
corresponding Graph/Chart) III-21

2. Japan III-22 A.Market Analysis III-22 Outlook III-22 Reimbursement Scenario
III-22 Competition III-22 Strategic Developments III-22 B.Market Analytics
III-23

Table 51: Japanese Recent Past, Current & Future Analysis for Sleep Apnea
Diagnostic and Therapeutic Devices by Product Segment - Diagnostic Devices
(Clinical/Fixed PSG, Ambulatory PSG, and Others (Screening Devices)), and
Therapeutic Devices (CPAP, Auto PAP, Bi-Level PAP, and Facial Interfaces (Masks
and Humidifiers)) Markets Independently Analyzed with Annual Sales in US$
Million for Years 2000 through 2010 (includes corresponding Graph/Chart) III-23

Table 52: Japanese Long-term Projections for Sleep Apnea Diagnostic and
Therapeutic Devices by Product Segment - Diagnostic Devices (Clinical/Fixed PSG,
Ambulatory PSG, and Others (Screening Devices)), and Therapeutic Devices (CPAP,
Auto PAP, Bi-Level PAP, and Facial Interfaces (Masks and Humidifiers)) Markets
Independently Analyzed with Annual Sales in US$ Million for Years 2011 through
2015 (includes corresponding Graph/Chart) III-24

Table 53: Japanese 10-Year Perspective for Sleep Apnea Diagnostic and
Therapeutic Devices by Product Segment - Diagnostic Devices (Clinical/Fixed PSG,
Ambulatory PSG, and Others (Screening Devices)), and Therapeutic Devices (CPAP,
Auto PAP, Bi-Level PAP, and Facial Interfaces (Masks and Humidifiers)) Markets
for Years 2003, 2008, and 2012 (includes corresponding Graph/Chart) III-25

3. Europe III-26 A.Market Analysis III-26 Outlook III-26 Trends & Issues III-26
Ambulatory PSGs Gaining over Clinical PSGs III-26 Competition III-27

Table 54: European Sleep Diagnostics Market (2007) - Percentage Breakdown of
Revenues for Embla, Respironics, Weinmann, Compumedics and Others (includes
corresponding Graph/Chart) III-27 Product Launches III-27 Strategic Developments
III-28 Select Players III-28 B.Market Analytics III-29

Table 55: European Recent Past, Current & Future Analysis for Sleep Apnea
Diagnostic and Therapeutic Devices by Geographic Region - France, Germany,
Italy, UK, Spain and Rest of Europe Markets Independently Analyzed with Annual
Sales in US$ Million for Years 2000 through 2010 (includes corresponding
Graph/Chart) III-29

Table 56: European Long-term Projections for Sleep Apnea Diagnostic and
Therapeutic Devices by Geographic Region - France, Germany, Italy, UK, Spain and
Rest of Europe Markets Independently Analyzed with Annual Sales in US$ Million
for Years 2011 through 2015 (includes corresponding Graph/Chart) III-30

Table 57: European 10-Year Perspective for Sleep Apnea Diagnostic and
Therapeutic Devices by Geographic Region - Percentage Breakdown of Value Sales
for France, Germany, Italy, UK, Spain and Rest of Europe Markets for Years 2003,
2008, and 2012 (includes corresponding Graph/Chart) III-31

Table 58: European Recent Past, Current & Future Analysis for Sleep Apnea
Diagnostic and Therapeutic Devices by Product Segment - Diagnostic Devices
(Clinical/Fixed PSG, Ambulatory PSG, and Others (Screening Devices)), and
Therapeutic Devices (CPAP, Auto PAP, Bi-Level PAP, and Facial Interfaces (Masks
and Humidifiers)) Markets Independently Analyzed with Annual Sales in US$
Million for Years 2000 through 2010 (includes corresponding Graph/Chart) III-32

Table 59: European Long-term Projections for Sleep Apnea Diagnostic and
Therapeutic Devices by Product Segment - Diagnostic Devices (Clinical/Fixed PSG,
Ambulatory PSG, and Others (Screening Devices)), and Therapeutic Devices (CPAP,
Auto PAP, Bi-Level PAP, and Facial Interfaces (Masks and Humidifiers)) Markets
Independently Analyzed with Annual Sales in US$ Million for Years 2011 through
2015 (includes corresponding Graph/Chart) III-33

Table 60: European 10-Year Perspective for Sleep Apnea Diagnostic and
Therapeutic Devices by Product Segment - Percentage Breakdown of Value Sales for
Diagnostic Devices (Clinical/Fixed PSG, Ambulatory PSG, and Others (Screening
Devices)), and Therapeutic Devices (CPAP, Auto PAP, Bi-Level PAP, and Facial
Interfaces (Masks and Humidifiers)) Markets for Years 2003, 2008, and 2012
(includes corresponding Graph/Chart) III-34

3a. France III-35 A.Market Analysis III-35 Outlook III-35 Snapshots III-35
B.Market Analytics III-36

Table 61: French Recent Past, Current & Future Analysis for Sleep Apnea
Diagnostic and Therapeutic Devices by Product Segment - Sleep Apnea Diagnostic
Devices and Sleep Apnea Therapeutic Devices Markets Independently Analyzed with
Annual Sales in US$ Million for Years 2000 through 2010 (includes corresponding
Graph/Chart) III-36

Table 62: French Long-term Projections for Sleep Apnea Diagnostic and
Therapeutic Devices by Product Segment - Sleep Apnea Diagnostic Devices and
Sleep Apnea Therapeutic Devices Markets Independently Analyzed with Annual Sales
in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
III-36

Table 63: French 10-Year Perspective for Sleep Apnea Diagnostic and Therapeutic
Devices by Product Segment - Percentage Breakdown of Value Sales for Sleep Apnea
Diagnostic Devices and Sleep Apnea Therapeutic Devices Markets for Years 2003,
2008, and 2012 III-37

3b. Germany III-38 A.Market Analysis III-38 Outlook III-38 Insurance &
Reimbursement Scenario III-38 Reimbursement for Sleep Apnea III-39 Physician
Support Vital for Market Penetration III-39 B.Market Analytics III-39

Table 64: German Recent Past, Current & Future Analysis for Sleep Apnea
Diagnostic and Therapeutic Devices by Product Segment - Sleep Apnea Diagnostic
Devices and Sleep Apnea Therapeutic Devices Markets Independently Analyzed with
Annual Sales in US$ Million for Years 2000 through 2010 (includes corresponding
Graph/Chart) III-39

Table 65: German Long-term Projections for Sleep Apnea Diagnostic and
Therapeutic Devices by Product Segment - Sleep Apnea Diagnostic Devices and
Sleep Apnea Therapeutic Devices Markets Independently Analyzed with Annual Sales
in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
III-40

Table 66: German 10-Year Perspective for Sleep Apnea Diagnostic and Therapeutic
Devices by Product Segment - Percentage Breakdown of Value Sales for Sleep Apnea
Diagnostic Devices and Sleep Apnea Therapeutic Devices Markets for Years 2003,
2008, and 2012 III-40

3c. Italy III-41 Market Analysis III-41

Table 67: Italian Recent Past, Current & Future Analysis for Sleep Apnea
Diagnostic and Therapeutic Devices by Product Segment - Sleep Apnea Diagnostic
Devices and Sleep Apnea Therapeutic Devices Markets Independently Analyzed with
Annual Sales in US$ Million for Years 2000 through 2010 (includes corresponding
Graph/Chart) III-41

Table 68: Italian Long-term Projections for Sleep Apnea Diagnostic and
Therapeutic Devices by Product Segment - Sleep Apnea Diagnostic Devices and
Sleep Apnea Therapeutic Devices Markets Independently Analyzed with Annual Sales
in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
III-42

Table 69: Italian 10-Year Perspective for Sleep Apnea Diagnostic and Therapeutic
Devices by Product Segment - Percentage Breakdown of Value Sales for Sleep Apnea
Diagnostic Devices and Sleep Apnea Therapeutic Devices Markets for Years 2003,
2008, and 2012 III-42

3d. The United Kingdom III-43 A.Market Analysis III-43 Outlook III-43 Snapshots
III-43 B.Market Analytics III-44

Table 70: UK Recent Past, Current & Future Analysis for Sleep Apnea Diagnostic
and Therapeutic Devices by Product Segment - Sleep Apnea Diagnostic Devices and
Sleep Apnea Therapeutic Devices Markets Independently Analyzed with Annual Sales
in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
III-44

Table 71: UK Long-term Projections for Sleep Apnea Diagnostic and Therapeutic
Devices by Product Segment - Sleep Apnea Diagnostic Devices and Sleep Apnea
Therapeutic Devices Markets Independently Analyzed with Annual Sales in US$
Million for Years 2011 through 2015 (includes corresponding Graph/Chart) III-44

Table 72: UK 10-Year Perspective for Sleep Apnea Diagnostic and Therapeutic
Devices by Product Segment - Percentage Breakdown of Value Sales for Sleep Apnea
Diagnostic Devices and Sleep Apnea Therapeutic Devices Markets for Years 2003,
2008, and 2012 III-45

3e. Spain III-46 Market Analysis III-46

Table 73: Spanish Recent Past, Current & Future Analysis for Sleep Apnea
Diagnostic and Therapeutic Devices by Product Segment - Sleep Apnea Diagnostic
Devices and Sleep Apnea Therapeutic Devices Markets Independently Analyzed with
Annual Sales in US$ Million for Years 2000 through 2010 (includes corresponding
Graph/Chart) III-46

Table 74: Spanish Long-term Projections for Sleep Apnea Diagnostic and
Therapeutic Devices by Product Segment - Sleep Apnea Diagnostic Devices and
Sleep Apnea Therapeutic Devices Markets Independently Analyzed with Annual Sales
in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
III-47

Table 75: Spanish 10-Year Perspective for Sleep Apnea Diagnostic and Therapeutic
Devices by Product Segment - Percentage Breakdown of Value Sales for Sleep Apnea
Diagnostic Devices and Sleep Apnea Therapeutic Devices Markets for Years 2003,
2008, and 2012 III-47

3f. Rest of Europe III-48 Market Analysis III-48

Table 76: Rest of Europe Recent Past, Current & Future Analysis for Sleep Apnea
Diagnostic and Therapeutic Devices by Product Segment - Sleep Apnea Diagnostic
Devices and Sleep Apnea Therapeutic Devices Markets Independently Analyzed with
Annual Sales in US$ Million for Years 2000 through 2010 (includes corresponding
Graph/Chart) III-48

Table 77: Rest of Europe Long-term Projections for Sleep Apnea Diagnostic and
Therapeutic Devices by Product Segment - Sleep Apnea Diagnostic Devices and
Sleep Apnea Therapeutic Devices Markets Independently Analyzed with Annual Sales
in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
III-49

Table 78: Rest of Europe 10-Year Perspective for Sleep Apnea Diagnostic and
Therapeutic Devices by Product Segment - Percentage Breakdown of Value Sales for
Sleep Apnea Diagnostic Devices and Sleep Apnea Therapeutic Devices Markets for
Years 2003, 2008, and 2012 III-49

4. Rest of World III-50 A.Market Analysis III-50 Outlook III-50 Australia III-50
Significant Demand for Sleep Apnea Therapeutic Devices III-50 Market Shares and
Players III-50

Table 79: Australian Sleep Apnea Therapeutic Devices Market (2007) - Percentage
Breakdown of Value Sales for ResMed, Respironics, Fisher & Paykel, Covidien and
Others (includes corresponding Graph/Chart) III-50 Compumedics Ltd - A Key Sleep
Diagnostics Player III-51 Fisher & Paykel - A Major Sleep Therapeutics Player
III-51 Distribution III-51

Table 80: Australian Sleep Apnea Therapeutic Devices Market (2007) - Percentage
Breakdown of Value Sales by Major Distribution Channels (includes corresponding
Graph/Chart) III-51 Pricing & Reimbursement III-51

Table 81: Australian CPAP Machines Market (2007) - Average Prices Charged by
Leading Players in A$ (includes corresponding Graph/Chart) III-52 B.Market
Analytics III-52

Table 82: Rest of World Recent Past, Current & Future Analysis for Sleep Apnea
Diagnostic and Therapeutic Devices by Product Segment - Diagnostic Devices
(Clinical/Fixed PSG, Ambulatory PSG, and Others (Screening Devices)), and
Therapeutic Devices (CPAP, Auto PAP, Bi-Level PAP, and Facial Interfaces (Masks
and Humidifiers)) Markets Independently Analyzed with Annual Sales in US$
Million for Years 2000 through 2010 (includes corresponding Graph/Chart) III-52

Table 83: Rest of World Long-term Projections for Sleep Apnea Diagnostic and
Therapeutic Devices by Product Segment - Diagnostic Devices (Clinical/ Fixed
PSG, Ambulatory PSG, and Others (Screening Devices)), and Therapeutic Devices
(CPAP, Auto PAP, Bi-Level PAP, and Facial Interfaces (Masks and Humidifiers))
Markets Independently Analyzed with Annual Sales in US$ Million for Years 2011
through 2015 (includes corresponding Graph/Chart) III-53

Table 84: Rest of World 10-Year Perspective for Sleep Apnea Diagnostic and
Therapeutic Devices by Product Segment - Percentage Breakdown of Value Sales for
Diagnostic Devices (Clinical/Fixed PSG, Ambulatory PSG, and Others (Screening
Devices)), and Therapeutic Devices (CPAP, Auto PAP, Bi-Level PAP, and Facial
Interfaces (Masks and Humidifiers)) Markets for Years 2003, 2008, and 2012
(includes corresponding Graph/Chart) III-54

IV. COMPETITIVE LANDSCAPE

- Astro-Med Inc. - Bio-Logic - Breas Medical - Cadwell Laboratories, Inc.-
Cardinal Health - Compumedics Ltd - Covidien Ltd - DeVilbiss Healthcare - Embla
- Fisher & Paykel - Flaga Group - Grass Technologies - Hoffman- Invacare
Corporation - Itamar Medical Ltd. - Medical Industries America Inc. - Natus
Medical Inc. - Nihon Kohden - Puritan - ResMed Inc. - RespCare - Respironics Inc
- Royal Philips - Stellate Systems, Inc. - Teijin - Teleflex - Tyco Healthcare -
VIASYS - Vital Signs Inc. - Weinmann Geräte für Medizin GmbH+CCo. KG - XLTEK

To order this report:World Sleep Apnea Diagnostic and Therapeutic Devices Market

http://www.reportlinker.com/p098389/World-Sleep-Apnea-Diagnostic-and-Therapeutic-Devices--Market.html

More market research reports here!

Reportlinker
Nicolas: nbo@reportlinker.com
US: (805)-652-2626
Intl: +1 805-652-2626

Copyright Business Wire 2009